Exalys Therapeutics
0 followers
‌
Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.
Industries
Employees
Links
Org chart
Rick Orr
Collapse
Julien Mamet
Chief Scientific Officer
Shashidhar Kori
Chief Medical Officer
Lynne Rollins
Chief Financial Officer
William Martin
EVP, Corporate Development & Operations
